Drug Resistance Updates
Volume 1, Issue 6 , Pages 397-406 , 1998

Dihydrofolate reductase and antifolate resistance in malaria

  • Worachart Sirawaraporn

      Affiliations

    • Corresponding Author InformationCorrespondence to: Worachart Sirawaraporn, Department of Biochemistry, Faculty of Science, Mahidol University, Rama VI Rd, Bangkok 10400, Thailand. Tel: 662 246 0063 ext. 6309; Fax: 662 248 0375

Received 25 June 1998 ,Revised 27 August 1998 ,Accepted 31 August 1998.

References 

  1. In: WHO Technical Report Series 805. Practical chemotherapy of malaria. WHO; 1990;p. 7–8
  2. Coggeshall LT. The selective action of sulfanilamide on the parasites of experimental malaria in monkeys in vivo and in vitro. J Exp Med. 1940;71:13–20
  3. Walker HA, van Dyke HB. Control of malaria infection (P. lophurae) in ducks by sulfonamides. In: Proc Soc Exp Biol Med. 48:1941;p. 368–372
  4. Maier J, Riley E. Inhibition of antimalarial action of sulfonamides by p-aminobenzoic acid. In: Proc Soc Exp Biol Med. 50:1942;p. 152–154
  5. McConkey GA, Ittarat I, Meshnick SR, McCutchan TF. Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth. In: Proc Natl Acad Sci USA. 91:1994;p. 4244–4248
  6. Roberts F, Roberts CW, Johnson JJ, et al. Evidence for the shikimate pathway in apicomplexan parasites. Nature. 1998;393:801–805
  7. Ferone R. Folate metabolism in malaria. Bull WHO. 1977;55:291–298
  8. Krungkrai J, Webster HK, Yuthavong Y. De novo and salvage biosynthesis of pteroyl polyglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol. 1989;32:25–38
  9. Asawamahasakda W, Yuthavong Y. The methionine synthesis cycle and salvage of methyltetrahydrofolate from host red cells in the malaria parasite (Plasmodium falciparum). Parasitology. 1993;107:1–10
  10. Krungkrai J, Webster HK, Yuthavong Y. Guanosine triphosphate cyclohydrolase in Plasmodium falciparum and other Plasmodium species. Mol Biochem Parasitol. 1985;17:265–276
  11. Brooks DR, Wang P, Read M, et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994;224:397–405
  12. Triglia T, Cowman AF. Primary structure and expression of the dihydropteroate synthase gene of the Plasmodium falciparum. In: Proc Natl Acad Sci USA. 91:1994;p. 7149–7153
  13. Ferone R. The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. J Protozool. 1973;20:459–463
  14. Triglia T, Menting JGT, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. In: Proc Natl Acad Sci USA. 94:1997;p. 13944–13949
  15. Ivanetich KM, Santi DV. Bifunctional thymidylate synthasedihydrofolate reductase in protozoa. FASEB J. 1990;4:1591–1597
  16. Garrett CE, Coderre JA, Meek TD, et al. A bifunctional thymidylate synthetase-dihydrofolate reductase in protozoa. Mol Biochem Parasitol. 1984;11:257–265
  17. Grumont R, Washtien WL, Caput D, Santi DV. Bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania tropica: sequence homology with the corresponding monofunctional proteins. In: Proc Natl Acad Sci USA. 83:1986;p. 5387–5391
  18. Beverley SM, Ellenberger TE, Cordingley JS. Primary structure of the gene encoding the bifunctional dihydrofolate reductasethymidylate synthase of Leishmania major. In: Proc Natl Acad Sci USA. 83:1986;p. 2584–2588
  19. Roos DS. Primary structure of the dihydrofolate reductasethymidylate synthase gene from Toxoplasma gondii. J Biol Chem. 1993;268:6269–6280
  20. Bzik DJ, Li W-B, Horii T, Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. In: Proc Natl Acad Sci USA. 84:1987;p. 8360–8364
  21. Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum. In: Proc Natl Acad Sci USA. 85:1988;p. 9114–9118
  22. Snewin VA, England SM, Sims PFG, Hyde JE. Characterization of the dihydrofolate reductase-thymidylate synthase from human malaria parasites highly resistant to pyrimethamine. Gene. 1989;76:41–52
  23. Hyde JE. The dihydrofolate reductase-thymidylate synthase gene in the drug resistance of malaria parasites. Pharmacol Ther. 1990;48:45–59
  24. Cowman AF, Morry MJ, Biggs BA, Cross GAM, Foote SJ. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. In: Proc Natl Acad Sci USA. 85:1988;p. 9109–9113
  25. Eldin de Pecoulas P, Basco LK, Tahar R, Ouatas T, Mazabraud A. Analysis of the Plasmodium vivax dihydrofolate reductasethymidylate synthase gene sequence. Gene. 1998;211:177–185
  26. Gutteridge WE, Trigg PI. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitro. Parasitology. 1971;62:431–444
  27. Bruce-Chwatt LJ, Black R, Canfield CJ, et al. Chemotherapy of Malaria. In: Geneva: WHO; 1986;
  28. Canfield CJ, Milhous WK, Ager AL, et al. A potent, orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg. 1993;49:121–126
  29. Peter W. Chemotherapy and Drug Resistance in Malaria. In: Peter W editors. Geneva: Academic; 1987;
  30. Wooden JM, Hartwell LH, Vasquez B, Sibley CH. Analysis in yeast of antimalarial drugs that the dihydrofolate reductase of Plasmodium falciparum. Mol Biochem Parasitol. 1997;85:25–40
  31. Hekmat-Nejad M, Rathod PK. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Expt Parasitol. 1997;87:222–228
  32. Fidock DA, Wellems TE. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. In: Proc Natl Acad Sci USA. 94:1997;p. 10931–10936
  33. Diggens SM, Gutteridge WE, Trigg PI. An altered dihydrofolate reductase associated with a pyrimethamine resistant P. berghei produced in a single step. Nature. 1970;228:579–580
  34. Ferone R. Dihydrofolate from pyrimethamine resistant. P. berghei. J Biol Chem. 1970;245:850–854
  35. Kan SC, Siddiqui WA. Comparative studies on dihydrofolate reductases from Plasmodium falciparum and Aotus trivirgatus. J Protozool. 1979;26:660–664
  36. Sirawaraporn W, Yuthavong Y. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi. Mol Biochem Parasitol. 1984;10:355–367
  37. Walter RD. Altered dihydrofolate reductase in pyrimethamine-resistant Plasmodium falciparum. Mol Biochem Parasitol. 1986;19:61–66
  38. Chen GX, Mueller C, Wendlinger M, Zolg JW. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Mol Pharmacol. 1987;31:430–437
  39. McCutchan TF, Welsh JA, Dame JB, et al. Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum. Antimicrob Agents Chemother. 1984;26:656–659
  40. Dieckmann A, Jung A. The mechanism of pyrimethamine resistance in Plasmodium falciparum. Parasitology. 1986;93:275–278
  41. Inselburg J, Bzik DJ, Horii T. Pyrimethamine resistant Plasmodium falciparum: overproduction of dihydrofolate reductase by a gene duplication. Mol Biochem Parasitol. 1987;26:121–134
  42. Cowman AF, Lew AM. Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi. Mol Cell Biol. 1989;9:5182–5188
  43. Tanaka M, Gu HM, Bzik DJ, et al. Mutant dihydrofolate reductasethymidylate synthase genes in pyrimethamine-resistant Plasmodium falciparum with polymorphic chromosome duplications. Mol Biochem Parasitol. 1990;42:83–91
  44. Thaithong S, Chan S-W, Songsomboon S, et al. Pyrimethamine resistant mutations in Plasmodium falciparum. Mol Biochem Parasitol. 1992;52:149–158
  45. Zolg JW, Plitt JR, Chen G-X, Palmer S. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol. 1989;36:253–262
  46. Hyde J. Point mutations and pyrimethamine resistance in Plasmodium falciparum. Parasitol Today. 1989;5:252–255
  47. Foote SJ, Galatis D, Cowman AF. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. In: Proc Natl Acad Sci USA. 87:1990;p. 3014–3017
  48. Basco LK, de Pecoulas PE, Wilson CM, et al. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol. 1995;69:135–138
  49. Basco LK, de Pecoulas PE, Le Bras J, Wilson CM. Plasmodium falciparum: Molecular characterization of multidrug-resistant Cambodian isolates. Expt Parasitol. 1996;82:97–103
  50. Peterson DS, Milhous WK, Wellems TE. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. In: Proc Natl Acad Sci USA. 87:1990;p. 3018–3022
  51. Sirawaraporn W, Sathitkul T, Sirawaraporn R, et al. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. In: Proc Natl Acad Sci USA. 94:1997;p. 1124–1129
  52. Reeder JC, Rieckmann KH, Genton B, et al. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg. 1996;55:209–213
  53. Zindrou S, Phuong Dung N, Duy Sy N, et al. Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient. Expt Parasitol. 1996;84:56–64
  54. Plowe CV, Cortese JF, Djimde A, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis. 1997;176:1590–1596
  55. Wang P, Lee C-S, Bayoumi R, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol. 1997;89:161–177
  56. Van Dijk MR, Waters AP, Janse CJ. Stable transfection of malaria parasite blood stages. Science. 1995;268:1358–1362
  57. Wu Y, Sifri CD, Lei H-H, et al. Transformation of Plasmodium falciparum within human red blood cells. In: Proc Natl Acad Sci USA. 92:1995;p. 973–977
  58. Van Dijk MR, Janse CJ, Waters AP. Expression of a Plasmodium gene introduced into subtelomic regions of Plasmodium berghei chromosomes. Science. 1996;271:662–665
  59. Wu Y, Kirkman LA, Wellems TE. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. In: Proc Natl Acad Sci USA. 93:1996;p. 1130–1134
  60. Raynolds MG, Roos DS. A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma dondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum. J Biol Chem. 1998;273:3461–3469
  61. Sirawaraporn W, Prapunwattana P, Sirawaraporn R, et al. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase: gene synthesis, expression, and anti-folate resistant mutants. J Biol Chem. 1993;268:21637–21644
  62. Hall SJ, Sim PFG, Hyde JE. Functional expression of the dihydrofolate reductase and thymidylate synthetase of the human malaria parasite Plasmodium falciparum in Escherichia coli. Mol Biochem Parasitol. 1991;45:317–330
  63. Sano GI, Morimatsu K, Horii T. Purification and characterization of dihydrofolate reductase of Plasmodium falciparum expressed by a synthetic gene in Escherichia coli. Mol Biochem Parasitol. 1994;63:265–273
  64. Hekmat-Nejad M, Lee P-C, Rathod PK. Plasmodium falciparum: direct cloning and expression of pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase domains. Expt Parasitol. 1997;85:303–305
  65. Knighton DR, Kan C-C, Howland E, et al. Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase. Nature Struct Biol. 1994;1:186–194
  66. Smith DR, Calvo JM. Nucleotide sequence of the E. coli gene coding for dihydrofolate reductase. Nucleic Acids Res. 1980;8:2255–2274
  67. Kumar AA, Blankenship DT, Kaufman BT, Freisheim JH. Primary structure of chicken liver dihydrofolate reductase. Biochemistry. 1980;19:667–678
  68. Masters JN, Attardi G. The nucleotide sequence of cDNA coding for the human dihydrofolic acid reductase. Gene. 1983;21:59–63
  69. Chen M-J, Shimada T, Moulton AD, et al. The functional human dihydrofolate reductase gene. J Biol. Chem. 1984;259:3933–3943
  70. Edman JC, Edman U, Cao M, et al. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. In: Proc Natl Acad Sci USA. 86:1989;p. 8625–8629
  71. Freisheim JH, Bitar KG, Reddy AV, Blankenship DT. Dihydrofolate reductase from amethopterin-resistant Lactobacillus casei. sequences of the cyanogen bromide peptides and complete sequences of the enzyme. J Biol Chem. 1978;253:6437–6444
  72. Kuntz ID, Blaney JM, Oatley SJ, et al. A geometric approach to macromolecule-ligand interactions. J Mol Biol. 1982;161:269–288
  73. Meng EC, Shoichet BK, Kuntz ID. Automated docking with gridbased energy evaluation. J Comp Chem. 1992;13:505–524
  74. Shoichet BK, Bodian DL, Kuntz ID. Molecular docking using shape description. J Comp Chem. 1992;13:380–397
  75. Leach AR. The use of molecular modelling to discover and design new molecules. In: Leach AR editors. Molecular Modellings: Principles and Applications. Edinburgh: Addison Wesley Longman Limited; 1996;p. 543–583
  76. Toyoda T, Brobey RKB, Sano G-I, Horii T. Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochem Biophys Res Comm. 1997;235:515–519
  77. McKie JH, Douglas KT, Chan C, et al. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria. J Med Chem. 1998;41:1367–1370

PII: S1368-7646(98)80015-0

Drug Resistance Updates
Volume 1, Issue 6 , Pages 397-406 , 1998

Article Tools